12/19/2024 8:55 PM | MiCo IVD Holdings, LLC (Filed by) Trinity Biotech (Subject)
| Form SCHEDULE 13D/A | |
12/18/2024 11:02 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2024 3:42 PM | Trinity Biotech (Filer)
| Form 424B5 | |
12/05/2024 3:30 PM | Trinity Biotech (Filer)
| Form 424B3 | |
12/02/2024 11:15 PM | Trinity Biotech (Filer)
| Form EFFECT | |
11/29/2024 3:45 PM | Trinity Biotech (Filer)
| Form F-3/A | |
11/15/2024 4:00 PM | Trinity Biotech (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
|
11/15/2024 12:22 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024 4:26 PM | PERCEPTIVE ADVISORS LLC (Filed by) Trinity Biotech (Subject)
| Form SC 13D/A | |
11/07/2024 11:33 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2024 12:23 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2024 12:24 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/07/2024 9:35 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2024 10:22 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 2:07 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2024 5:01 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024 7:11 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024 4:14 PM | Trinity Biotech (Filer)
| Form 424B5 | |
09/10/2024 9:35 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2024 12:26 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2024 9:52 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/04/2024 10:59 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2024 5:01 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024 11:33 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/21/2024 3:40 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/20/2024 12:52 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024 4:26 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024 4:27 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024 4:03 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024 3:53 PM | Trinity Biotech (Filer)
| Form 424B5 | |
07/11/2024 5:55 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/30/2024 11:15 PM | Trinity Biotech (Filer)
| Form EFFECT | |
06/28/2024 1:34 PM | Trinity Biotech (Filer)
| Form F-3/A | |
06/21/2024 3:15 PM | Trinity Biotech (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
05/28/2024 6:55 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024 12:15 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024 11:15 PM | Trinity Biotech (Filer)
| Form EFFECT | |
05/07/2024 3:25 PM | Trinity Biotech (Filer)
| Form 424B3 | |
04/30/2024 4:14 PM | Trinity Biotech (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
04/30/2024 2:48 PM | Trinity Biotech (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
04/30/2024 11:28 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Buy this coin BEFORE Inauguration Day … (Ad) Mark my words … Bitcoin is going to $100,000.
BEFORE Trump is inaugurated.
And I think it could reach $125,000 by the end of his first month in office. This could be his favorite coin. |
04/05/2024 12:05 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/15/2024 1:11 PM | Trinity Biotech (Filer)
| Form 424B3 | |
02/09/2024 6:51 PM | PERCEPTIVE ADVISORS LLC (Filed by) Trinity Biotech (Subject)
| Form SC 13D | |
02/01/2024 10:33 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/01/2024 10:37 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/02/2024 3:17 PM | MiCo IVD Holdings, LLC (Filed by) Trinity Biotech (Subject)
| Form SC 13D/A | |
01/02/2024 3:13 PM | MiCo Co., Ltd. (Filed by) Trinity Biotech (Subject)
| Form SC 13D/A | |
01/02/2024 1:02 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |